Fibrin-polylactide-based tissue-engineered vascular graft in the arterial circulation

Biomaterials

Volumn 31, Issue 17, 2010, Pages 4731-4739

  Koch, Sabine ^a   Flanagan, Thomas C ^a,b   Sachweh, Joerg S ^a   Tanios, Fadwa ^a   Schnoering, Heike ^a   Deichmann, Thorsten ^c   Ellä, Ville ^d   Kellomäki, Minna ^d   Gronloh, Nina ^e   Gries, Thomas ^c   Tolba, René ^e   Schmitz Rode, Thomas ^a   Jockenhoevel, Stefan ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Animal experiment; Artery; Fibrin; Grafting; Tissue engineering

Indexed keywords

ANEURYSM FORMATION; ANIMAL EXPERIMENT; ANIMAL EXPERIMENTS; ARTERIAL GRAFTS; CAROTID ARTERY; CELL DISTRIBUTION; CONFLUENT MONOLAYERS; DESIGN AND DEVELOPMENT; FIBRIN SCAFFOLD; GRAFT WALL; HISTOLOGICAL ANALYSIS; IN-VIVO; LACTIDES; POLY LACTIDE; PRE-CLINICAL; SMALL-DIAMETER; STUDY GROUPS; THROMBUS FORMATION; TISSUE-ENGINEERED ARTERY; VASCULAR GRAFTS;

ANIMALS; BIOMINERALIZATION; ENDOTHELIAL CELLS; EXPERIMENTS; GRAFTING (CHEMICAL); MONOLAYERS; SCAFFOLDS; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

GRAFTS;

FIBRIN; HYDROXYPROLINE; POLYLACTIDE;

ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL CIRCULATION; ARTICLE; BLOOD VESSEL GRAFT; CAROTID ARTERY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SHEEP; STENOSIS; THROMBOGENESIS; TISSUE ENGINEERING;

ANIMALS; CAROTID ARTERIES; CELLS, CULTURED; COLLAGEN; ENDOTHELIAL CELLS; FEMALE; FIBRIN; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCYTES, SMOOTH MUSCLE; POLYESTERS; SHEEP; TISSUE ENGINEERING;

ANIMALIA; OVIS ARIES;

EID: 77951090541     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.02.051     Document Type: Article

References (36)

1. American Heart Association Heart disease and stroke statistics - 2009 update. Circulation 2009, 119:e21-e181.
2. Kannan R.Y., Salacinski H.J., Butler P.E., Hamilton G., Seifalian A.M. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater 2005, 74:570-581.
3. Sapsford R.N., Oakley G.D., Talbot S. Early and late patency of expanded polytetrafluoroethylene vascular grafts in aorta-coronary bypass. J Thorac Cardiovasc Surg 1981, 81:860-864.
4. Veith F.J., Gupta S.K., Ascer E., White-Flores S., Samson R.H., Scher L.A., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986, 3:104-114.
5. Klinkert P., Post P.N., Breslau P.J., van Bockel J.H. Saphenous vein versus PTFE for above-knee femoropopliteal bypass: a review of the literature. Eur J Vasc Endovasc Surg 2004, 27:357-362.
6. Canver C.C. Conduit options in coronary artery bypass surgery. Chest 1995, 108:1150-1155.
7. Nerem R.M., Seliktar D. Vascular tissue engineering. Annu Rev Biomed Eng 2001, 3:225-243.
8. van der Giessen W.J., Lincoff A.M., Schwartz R.S., van Beusekom H.M., Serruys P.W., Holmes D.R., et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996, 94:1690-1697.
9. Athanasiou K.A., Niederauer G.G., Agrawal C.M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996, 17:93-102.
10. Weinberg C.B., Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231:397-400.
11. Pool J.G., Gershgold E.J., Pappenhagen A.R. High potency anti-haemophilic factor prepared from cryoglobulin precipitate. Nature 1964, 203:312.
12. Haisch A., Loch A., David J., Pruss A., Hansen R., Sittinger M. Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering. Med Biol Eng Comput 2000, 38:686-689.
13. Jockenhoevel S., Zund G., Hoerstrup S.P., Chalabi K., Sachweh J.S., Demircan L., et al. Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2001, 19:424-430.
14. Cholewinski E., Dietrich M., Flanagan T.C., Schmitz-Rode T., Jockenhoevel S. Tranexamic acid - an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng Part A 2009, 15:3645-3653.
15. Grassl E.D., Oegema T.R., Tranquillo R.T. Fibrin as an alternative biopolymer to type-I-collagen for the fabrication of a media equivalent. J Biomed Mater Res 2002, 60:607-612.
16. Flanagan T.C., Sachweh J.S., Frese J., Schnöring H., Gronloh N., Koch S., et al. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng Part A 2009, 15:2965-2976.
17. Swartz D.D., Russell J.A., Andreadis S.T. Engineering of fibrin-based functional and implantable small-diameter blood vessels. Am J Physiol Heart Circ Physiol 2005, 288:H1451-H1460.
18. Tschoeke B., Flanagan T.C., Koch S., Sri Harwoko M., Deichmann T., Ella V., et al. Tissue-engineered small caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold. Tissue Eng Part A 2009, 15:1909-1918.
19. Ellä V., Gomes M.E., Reis R., Törmälä P., Kellomäki M. Studies of P(L/D)LA 96/4 non-woven scaffolds and fibers; properties, wettability and cell spreading before and after intrusive treatment methods. J Mater Sci Mater Med 2007, 18:1253-1261.
20. Hata R., Senoo H. L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissue-like substance by skin fibroblasts. J Cell Physiol 1989, 138:8-16.
21. Ye Q., Zund G., Benedikt P., Jockenhoevel S., Hoerstrup S.P., Sakyama S., et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000, 17:587-591.
22. Shum-Tim D., Stock U., Hrkach J., Shinoka T., Lien J., Moses M.A., et al. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 1999, 68:2298-2305.
23. Shinoka T., Imai Y., Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001, 344:532-533.
24. Hoerstrup S.P., Cummings I., Lachat M., Schoen F.J., Jenni R., Leschka S., et al. Functional growth in tissue-engineered living, vascular grafts: follow-up at 100 weeks in a large animal model. Circulation 2006, 114(Suppl. I):I159-I166.
25. Shinoka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005, 129:1330-1338.
26. Mirensky T.L., Nelson G.N., Brennan M.P., Roh J.D., Hibino N., Yi T., et al. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. J Pediatr Surg 2009, 44:1127-1132.
27. L'Heureux N., Dusserre N., Konig G., Victor B., Keire P., Wight T.N., et al. Human tissue engineered blood vessel for adult arterial revascularization. Nat Med 2006, 12:361-365.
28. McAllister T.N., Maruszewski M., Garrido S.A., Wystrychowski W., Dusserre N., Marini A., et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multcenter cohort study. Lancet 2009, 373:1440-1446.
29. Jackson M.R. Fibrin sealants in surgical practice: an overview. Am J Surg 2001, 182:S1-S7.
30. Eppley B.L., Pietrzak W.S., Blanton M. Platelet-rich plasma: a review of biology and applications in plastic surgery. Plast Reconstr Surg 2006, 118:e147-e159.
31. Ferreira L., Karp J.M., Nobre L., Langer R. New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell 2008, 3:136-146.
32. Hoffman D., Gong G., Liao K., Macaluso F., Nikolic S.D., Frater R.W. Spontaneous host endothelial growth on bioprostheses. Influence of fixation. Circulation 1992, 86:I175-I179.
33. Butenas S., Mann K.G. Blood coagulation. Biochemistry (Mosc) 2002, 67:3-12.
34. Aper T., Teebken O.E., Steinhoff G., Haverich A. Use of a fibrin preparation in the engineering of a vascular graft model. Eur J Vasc Endovasc Surg 2004, 28:296-302.
35. Kadner A., Hoerstrup S.P., Zund G., Eid K., Maurus C., Melnitchouk S., et al. A new source for cardiovascular tissue engineering: human bone marrow stromal cells. Eur J Cardiothorac Surg 2002, 21:1055-1060.
36. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science 1997, 275:964-967.